Ryon P Graf

26PUBLICATIONS

127CO-AUTHORS

Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jul 10, 2026

Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.

|May 14, 2026

Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

|Mar 31, 2026

Clinical value of tumor mutational burden for neoadjuvant and adjuvant immune checkpoint inhibitor in early-stage non-small cell lung cancer.

Julia C F Quintanilha, Gerald Li, Ryon P Graf

|Mar 23, 2026

The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.

Jessica K Lee, Julia C F Quintanilha, Kuei-Ting Chen

|Dec 04, 2025

Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

|Oct 09, 2025

LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial.

Andrew J Armstrong, Hilary Dietz, David Balli

Pageof 5

Frequent Collaborators

10 joint publications

Geoffrey R Oxnard

10 joint publications

Richard Sheng Poe Huang

Gerald Li

Alexa B Schrock

Jeffrey S Ross

Julia C F Quintanilha

4 joint publications

Emmanuel S Antonarakis

4 joint publications

Virginia Fisher

4 joint publications

Neeraj Agarwal

4 joint publications

Douglas Lin

Frequent Collaborators

10 joint publications

Geoffrey R Oxnard

10 joint publications

Richard Sheng Poe Huang

9 joint publications

Gerald Li

7 joint publications

Alexa B Schrock